These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8630647)

  • 1. Pharmacologic treatment of children and adolescents with obsessive-compulsive disorder.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1995; 8(4):36-40. PubMed ID: 8630647
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder.
    Grados M; Scahill L; Riddle MA
    Child Adolesc Psychiatr Clin N Am; 1999 Jul; 8(3):617-34, x. PubMed ID: 10442233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors.
    Cohen SE; Denys DAJP; Mattila TK; Storosum BWC; de Boer A; Zantvoord JB
    BMJ Ment Health; 2024 Jun; 27(1):. PubMed ID: 38901870
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
    Hammerness PG; Vivas FM; Geller DA
    J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing of discontinuing SSRIs in OCD.
    Manassis K; Owens M
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):499-500. PubMed ID: 10230179
    [No Abstract]   [Full Text] [Related]  

  • 8. Obsessive-compulsive disorders.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2013 Feb; 22 Suppl 1():S23-8. PubMed ID: 23208425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
    JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package.
    March JS; Mulle K; Herbel B
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):333-41. PubMed ID: 8169177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Drug Ther Bull; 1995 Jun; 33(6):47-8. PubMed ID: 7587998
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Grados MA; Ginsburg GS; Drake KL; Kingery JN
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):573-574. PubMed ID: 19395904
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
    Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
    Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder in Tourette syndrome.
    Goodman WK; Storch EA; Geffken GR; Murphy TK
    J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.
    Humble M; Bejerot S; Bergqvist PB; Bengtsson F
    Biol Psychiatry; 2001 Feb; 49(4):360-8. PubMed ID: 11239907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatry of obsessive-compulsive disorder in children and adolescents.
    March JS; Leonard HL; Swedo SE
    Compr Ther; 1995 Sep; 21(9):507-12. PubMed ID: 8565438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapies in the management of obsessive-compulsive disorder.
    Blier P; Habib R; Flament MF
    Can J Psychiatry; 2006 Jun; 51(7):417-30. PubMed ID: 16838823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder.
    Owley T; Owley S; Leventhal B; Cook EH
    J Child Adolesc Psychopharmacol; 2002; 12(2):165-71. PubMed ID: 12188985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.